Zhong Nanshan

Last updated

Li Shaofen  [ zh ]
​
​
(m. 1963)​
Professor
Zhong Nanshan
FRCPE FRCP FRCPI
钟南山
Zhong Nanshan (cropped).jpg
Zhong in 2015
Member to the National People's Congress
(11th, 12th)
In office
March 2008 –March 2018
Children3
Alma mater Peking University Health Science Center
University of Edinburgh Medical School
Occupation pulmonologist
Awards Medal of the Republic (2020)
Known forDiscovering the SARS coronavirus
Scientific career
Fields Pulmonology, respiratory diseases
Institutions Guangzhou Institute of Respiratory Diseases
Guangzhou Medical University
Chinese name
Simplified Chinese 钟南山
Traditional Chinese 鍾南山
Literal meaning Zhong South-mountain
Transcriptions
Standard Mandarin
Hanyu Pinyin Zhōng Nánshān
IPA [ʈʂʊ́ŋ nǎnʂán]
Yue: Cantonese
Yale Romanization Jūng Nàahm-sāan
Jyutping Zung1 Naam4-saan1
IPA [tsʊŋ˥ nam˩san˥]
Southern Min
Hokkien POJ Cheng Lâm-soaⁿ

Zhong Nanshan (born 20 October 1936) [1] is a Chinese pulmonologist. [2] He was president of the Chinese Medical Association from 2005 to 2009 and is currently the editor-in-chief of the Journal of Thoracic Disease . [2] Zhong was bestowed the Medal of the Republic, the highest honorary medal of the People's Republic of China, in August 2020. [3]

Contents

Zhong earned international fame for managing the SARS outbreak [4] and was renowned for refuting the official line which downplayed the severity of the crisis. [5] He was voted one of China's top 10 scientists in 2010. [6]

During the COVID-19 pandemic which was first identified in Wuhan, Hubei, Zhong was a leading advisor in managing the crisis, suggesting evidence-based control measures to contain the disease and sharing the successful treatment plan with the international community. [5] [7] He was named by Time as one of the 100 most influential people in the world in 2020. [7]

Early life and education

Zhong was born on 20 October 1936 at the Central Hospital in Nanjing，Because the hospital is located south of Zhongshan in Nanjing, his parents named it "Nanshan" according to the location of his birthplace., [1] [8] though his family was from Fujian province. [9] He was educated at Beijing Medical University, where he finished his residency training in internal medicine. After graduating from university in 1960, Zhong Nanshan had few opportunities to participate in clinical medicine. He once taught medicine, worked as a worker, and edited the school newspaper until he was transferred back to the Affiliated Hospital of Guangzhou Medical College in 1971. Zhong completed further training at St Bartholomew's Hospital in London and the University of Edinburgh Medical School between 1979 and 1981, graduating from the University of Edinburgh Medical School with an MD in 1981. [2]

Career

Zhong Nanshan was awarded the title of one of the first batch of national-level experts with outstanding contributions in 1984. Served as graduate tutor in 1985.In 1995, he became a doctoral supervisor. In May 1996, he was elected as an academician of the Chinese Academy of Engineering.Zhong became president of the Chinese Thoracic Society in 2000 and became president of the Chinese Medical Association in 2005. He is currently the director of the Guangzhou Institute of Respiratory Diseases and editor-in-chief of the Journal of Thoracic Disease. [2] Zhong discovered the relationship between protein malnutrition and COPD and has developed a calibrated formula on energy consumption for patients with COPD. [8]

SARS outbreak

When Zhong directed the Guangzhou Institute of Respiratory Diseases, they received the second case of a SARS patient as early as 20 December 2002. Over the next month, 28 similar cases were reported in Zhongshan alone, and on 21 January 2003, Zhong and other doctors and researchers in related fields reported this disease at an emergency meeting and gave it the name atypical pneumonia. [10]

On 28 January 2003, Zhong felt sick and discovered that he had caught pneumonia. Concerned that the news that a leading researcher and doctor for respiratory diseases falling ill during the SARS outbreak would cause fear and panic for the general public, Zhong decided to not receive treatment in the hospital.[ citation needed ] Instead he returned home, hoping that it was not caused by SARS and that he could recover without treatment. With care from his wife, Li Shaofen, he managed to recover after eight days. After recovery he immediately returned to the Guangzhou Institute of Respiratory Diseases to direct the fight against SARS. On 11 February 2003, at a press conference held by the Guangdong Department of Health, Zhong explained the disease and its symptoms, and calmed the public by asserting that it was "preventable" and "curable". [10]

Zhong, for the first time while treating SARS patients, employed non-invasive ventilation methods that increased the amount of oxygen that the patients could take in and alleviated pain. Zhong also insisted on proposing the use of cortisone for the treating of patients experiencing severe conditions, which significantly lowered the death rate of severe patients to 13% and decreased the total treatment time.[ citation needed ]

The decision to use cortisone was politically controversial at the time. In February 2003 the Chinese Center for Disease Control and Prevention had already published the authoritative view that normal Chlamydia was the direct cause of atypical pneumonia and, as a result, the only legally prescribed way of treating SARS patients was to use antibiotics. Based on observations of hundreds of patients in Guangdong, Zhong was determined to advocate for the moderate usage of cortisone. Zhong said later in an interview that he knew this might bring dishonor and defamation, but he persisted because he trusted in his observations and scientific judgements regarding the disease. [10]

With the support of the Guangdong government and the positive results in Guangdong in the treating of SARS disease, Zhong's method was later used as the standard protocol for treating all SARS patients in China. [10]

When delegates led by Dr. Evans from the World Health Organization visited China in early April, Zhong presented the characteristics of SARS as well as the treatment and prevention method in China. Zhong's presentation was well-received and his methods were adopted around the world. [10]

COVID-19

In early January 2020, Zhong visited Wuhan, in response to a growing cluster of then-unidentified pneumonia cases, and was reassured by city health officials that the disease was controllable and preventable. On 20 January, however, he returned to Wuhan, to re-evaluate the situation, and came to the conclusion that the novel coronavirus was more transmissible than previously identified, and warned the Central Committee of the Chinese Communist Party [11] that authorities in Wuhan were likely understating the severity of the outbreak, and on the same day, publicly announced on state television the same. [11] In later reporting of his state TV broadcast he recommended that "a quarantine period of 10 days to two weeks is very effective, so there will not be a large-scale infection as people travel back from their holidays" but also concluded with the prediction that "the virus outbreak may recede in a week to 10 days."

Zhong has compiled a coronavirus diagnosis and treatment protocol, and has made great contributions to the prevention and control of epidemics, treatment of severe cases, and COVID-19 research. In August 2020, he received from Chinese leader Xi Jinping the Medal of the Republic, the highest state honor, for his outstanding contribution to fighting the COVID-19 epidemic. [12]

During the pandemic, Zhong had promoted publicly [13] the usage of a controversial [14] traditional Chinese medicine of Lianhua Qingwen capsule for treating Covid-19 infection. Though later he had denied any commercial tie with the pharmaceutical company that supplies the capsule, [15] on 4 May 2021, an article from Retraction Watch [16] showed that Zhong and his coworkers were financially tied to the Yiling Pharmaceutical company that supplies the capsule.

In 2020, Zhong worked with Tencent to establish an AI Joint Lab to conduct research on disease screening, prevention, and outbreak warnings. [17] Zhong also worked on pandemic research projects with Foxconn and Alibaba Cloud. [17]

Honors

Awards and Prizes

On 12 December 2020, the Affiliated High School of South China Normal University unveiled a bronze statue of Zhong Nanshan was unveiled on its 132nd anniversary. [22]

Paper of the Year
  • The Lancet; 2008: The editorial board praised Zhong and his team, as they "clarified that carbocisteine can prevent the worsening of chronic obstructive pulmonary disease and can improve life at an affordable price, which is of great significance to developing countries." (Note: The editorial board selected six papers for readers to vote, and announced two winners, one selected by the editorial board and one with the highest reader votes. Zhong's paper obtained the highest number of votes.) [23] [24]
Professional Titles
  • 1989: Fellow of the American College of Chest Physicians [21]
  • 1993: Member of the European Respiratory Society [21]
  • 2005: Fellow of the Royal College of Physicians of Ireland [21]
  • 2011: Fellow of the Royal College of Physicians of Edinburgh [21]
  • 201?: Fellow of the Royal College of Physicians of London [25]
Honorary Degrees
  • 2005: Honorary Fellow of Hong Kong Academy of Medicine [21]
  • 2008: Honorary Fellow of the European Respiratory Society [21]
  • 2007: Doctor of Medicine (Honors), University of Edinburgh [26]
  • 2011: Honorary Doctor of Science, University of Birmingham
  • 2013: Honorary Doctor of Science, The Chinese University of Hong Kong [27]
Professional Societies
  • 1985–1990: Member, WHO Advisory Panel on Smoking & Health [21]
  • 1982–1985: Member, Executive Committee, Chinese Medical Association [21]
  • 1989–2000: Member, Executive Committee, American College of Chest Physicians [21]
  • 1989–present: Fellow, American College of Chest Physicians (FCCP) [21]

Personal life

Zhong Nanshan and Li Shaofen in 1963 Zhong Nanshan and Li Shaofen in 1963.jpg
Zhong Nanshan and Li Shaofen in 1963

Zhong was an outstanding college athlete in the 1950s. The Beijing Municipal Track and Field Team attempted to recruit him as a full-time athlete, but he was determined to become a doctor and declined the offer. Through his sports connection, he was introduced to Li Shaofen  [ zh ], a basketball player who was a member of the China women's national basketball team for 13 years. And won the 1964 French "Four Nations" women's basketball championship. But because Li Shaofen was a member of the national women's basketball team at the time and could not get married, Zhong Nanshan waited for her for eight years. They married on 31 December 1963. [28] They have two children: son Zhong Weide, a physician,he is a doctor in the Urology Department of Guangzhou First People's Hospital and the absolute main force of the hospital's basketball team,and daughter Zhong Weiyue, a swimmer, once won the short course world championship. [29] His father, Zhong Shifan, is a doctor of medicine from the State University of New York and a pediatric medical expert. His mother, Liao Yueqin, graduated from Peking Union Medical College and is the founder of Guangdong Cancer Hospital.

See also

Related Research Articles

<span class="mw-page-title-main">SARS</span> Disease caused by severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.

<span class="mw-page-title-main">2002–2004 SARS outbreak</span> Epidemic of severe acute respiratory syndrome originating in China

The 2002–2004 outbreak of SARS, caused by severe acute respiratory syndrome coronavirus, infected over 8,000 people from 30 countries and territories, and resulted in at least 774 deaths worldwide.

<span class="mw-page-title-main">Kwong Wah Hospital</span> Hospital in Kowloon, Hong Kong

Kwong Wah Hospital is a 1,141-bed Charitable hospital in Yau Ma Tei, Hong Kong. Located on 25 Waterloo Road, Kwong Wah Hospital is the main district general hospital was founded by the Tung Wah Group in 1911, and managed by the Hospital Authority since 1991. It provides a full range of medical services to the population of West Kowloon and Wong Tai Sin. It is Kowloon Central Cluster's major acute teaching hospital, and also a Neurosurgical and Antenatal Diagnosis referral centre. The Hospital has established various clinical centers, including Lai Kwok Wing Urology Centre, Minimally Invasive Surgery Training Centre and Chan Feng Men Ling Cardiac Centre. There are integrated Breast Centre and Dr Stephen Chow Chun-kay Assisted Reproduction Centre. It has established a Community Based Geriatric Service, Respiratory Care Unit, Acute Stroke Unit, TWGHs BOCHK Diabetes Centre, Wong Wha San Renal Memorial Centre, and a Nuclear Medicine site. Kwong Wah Hospital is also a pioneer in Integrative Chinese and Western Medicine. TWGHs has established TWGHs Wilson T S Wang Integrated Chinese and Western Medicine Treatment Centre in Kwong Wah. The hospital has participated through joint consultation for designated diseases under protocols which developed by both Chinese Medicine and Western Medicine practitioners.

<span class="mw-page-title-main">W. Ian Lipkin</span> Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

<span class="mw-page-title-main">Peter Barnes (respiratory scientist)</span> British pulmonary scientist and clinician

Sir Peter John Barnes, FRCP, FCCP, FMedSci, FRS is a British respiratory scientist and clinician, a specialist in the mechanisms and treatment of asthma and chronic obstructive pulmonary disease (COPD). He was Margaret Turner-Warwick Professor of Thoracic Medicine at the National Heart & Lung Institute, previous head of respiratory medicine at Imperial College and honorary consultant physician at the Royal Brompton Hospital London. He is one of the most highly cited scientists in the world

The Journal of Thoracic Disease is a peer-reviewed open access medical journal covering pulmonology. It was established in December 2009 and is published monthly by AME Publishing Company. It is the official journal of the State Key Laboratory of Respiratory Disease, the Guangzhou Institute of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, and the Society for Thoracic Disease. The editor-in-chief is Zhong Nanshan. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.365.

<span class="mw-page-title-main">Li Lanjuan</span> Chinese epidemiologist (born 1947)

Li Lanjuan, also romanized as Lan-Juan Li, is a Chinese epidemiologist and hepatologist. She is a professor at Zhejiang University School of Medicine, an academician of the Chinese Academy of Engineering, and serves as the director of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases. She developed Li-NBAL, an artificial liver support system that is used to sustain the lives of people suffering from acute liver failure, and won multiple national awards for her roles in combatting the SARS, H1N1, and H7N9 epidemics.

<span class="mw-page-title-main">COVID-19</span> Contagious disease caused by SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. Most scientists believe the SARS-CoV-2 virus entered into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Social and environmental factors including climate change, natural ecosystem destruction and wildlife trade increased the likelihood of such zoonotic spillover. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

<span class="mw-page-title-main">Li Wenliang</span> Chinese ophthalmologist (1985–2020)

Li Wenliang was a Chinese ophthalmologist who warned his colleagues about early COVID-19 infections in Wuhan.

<span class="mw-page-title-main">Dale Fisher</span> Australian physician (born 1960)

Dale Andrew Fisher FRACP is an infectious diseases physician who specialises in Infectious Diseases and a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore, and the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore. In 2020, he became group chief of Medicine for National University Health Systems.

The COVID-19 pandemic in Hubei was the first identified outbreak of the virus. It emerged as a cluster of mysterious pneumonia cases in Wuhan, the provincial capital of Hubei, China. A Wuhan hospital initially notified the local Center for Disease Control and Prevention (CDC) on December 27, 2019. By December 31, the Wuhan CDC confirmed a cluster of unknown pneumonia cases linked to the Huanan Seafood Wholesale Market after unverified documents appeared on the Internet. The outbreak soon drew nationwide attention, with the National Health Commission (NHC) in Beijing sending medical experts to Wuhan the next day. On January 8, 2020, a new coronavirus was identified as the cause of the pneumonia. The sequence of the virus was soon published on an open-access database. The measures taken by China have been controversial. They were praised by the World Health Organization (WHO) for improvements over their response to SARS-CoV-2. However, many in the international community maligned them for being deceptive, slow to publicly disclose key facts about the outbreak, and for aggressively censoring information related to the outbreak and public discontent from citizens online.

The Wuhan Jinyintan Hospital is a public hospital located on Jinyintan Avenue in the Jiangjunlu Subdistrict, in the Dongxihu District of Wuhan, Hubei, China, and a unit directly under the Wuhan Municipal Health and Health Committee. Jinyintan Hospital specialises in infectious diseases. Jinyintan Hospital is one of the designated hospitals for emergency medical treatment in Hubei, including Wuhan. The hospital's president is Dr. Zhang Dingyu, a respiratory specialist. Its vice-director is Dr. Huang Chaolin.

<span class="mw-page-title-main">Wang Guangfa</span> Chinese respiratory expert at Peking University First Hospital

Wang Guangfa is a Chinese physician. He is a respiratory expert at Peking University First Hospital.

Zhang Jixian is a Chinese pulmonologist. She is known to have discovered SARS‑CoV‑2, and was the director of the Department of Respiratory Medicine of Hubei Provincial Hospital of Integrated Chinese & Western Medicine. She is also a member of the Chinese Communist Party.

<span class="mw-page-title-main">Timeline of the COVID-19 pandemic in 2019</span> Sequence of major events in a virus pandemic

This article documents the chronology and epidemiology of SARS-CoV-2 in 2019, the virus that causes coronavirus disease 2019 (COVID-19) and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 known to have been identified were in Wuhan, Hubei, China, in December 2019. It marked the beginning of the 2019–2020 COVID-19 outbreak in mainland China.

<span class="mw-page-title-main">Chuang Yin-ching</span> Taiwanese epidemiologist

Kenneth Chuang Yin-ching is a Taiwanese epidemiologist. As of January 2020, he leads the Taiwan Centers for Disease Control (TCDC) Communicable Disease Control Medical Network.

The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the estimated millions of immunocompromised persons who are unlikely to respond robustly to vaccination, treatment remains important. Some people may experience persistent symptoms or disability after recovery from the infection, known as long COVID, but there is still limited information on the best management and rehabilitation for this condition.

<span class="mw-page-title-main">Zhang Boli (physician)</span> Chinese physician

Zhang Boli is a Chinese physician.

<span class="mw-page-title-main">Lianhua Qingwen</span> Traditional Chinese medicine formulation used for the treatment of influenza

Lianhua Qingwen is a traditional Chinese medicine (TCM) formulation used for the treatment of influenza. In the practice of TCM, LHQW is considered to have the effects of clearing excessive heat, removing toxins, improving lung ventilation, and discharging heat.

<i>Chinese Doctors</i> 2021 Chinese film

Chinese Doctors is a 2021 Chinese disaster film co-produced, co-cinematographed and directed by Andrew Lau and starring Zhang Hanyu, Yuan Quan, Zhu Yawen, Li Chen, with Jackson Yee and Oho Ou. The film follows the story of frontline medical workers who fought against the COVID-19 pandemic in Wuhan Jinyintan Hospital, Hubei, China. The film premiered in China on 9 July 2021, to commemorate the 100th anniversary of the Chinese Communist Party. The film received mixed to positive reviews and won Best Music at the 34th Golden Rooster Awards.

References

  1. 1 2 钟南山 (in Chinese (China)). Chinese Academy of Engineering. Archived from the original on 23 June 2016. Retrieved 18 February 2016.
  2. 1 2 3 4 "Editor-in-Chief: Prof. Dr. Zhong Nanshan, MD". Journal of Thoracic Disease. Archived from the original on 17 July 2013. Retrieved 18 July 2013.
  3. ↑ "敢医敢言，生命至上——记"共和国勋章"获得者钟南山-新华网". www.xinhuanet.com. Retrieved 10 October 2024.
  4. ↑ "SARS hero Zhong Nanshan named China's best scientist". whatsonxiamen. Archived from the original on 3 February 2015. Retrieved 18 July 2013.
  5. 1 2 "The coronavirus discovered in China is causing global alarm". The Economist. 23 January 2020. ISSN   0013-0613. Archived from the original on 26 January 2020. Retrieved 29 January 2020.
  6. ↑ "SARS hero named among China's 10 best scientists, technicians". Xinhua. Archived from the original on 20 December 2010. Retrieved 20 July 2013.
  7. 1 2 "Zhong Nanshan: The 100 Most Influential People of 2020". Time. Retrieved 23 September 2020.
  8. 1 2 "Zhong Nanshan". The HoLeung Ho Lee Foundation. Archived from the original on 6 June 2014. Retrieved 20 July 2013.
  9. ↑ 院士钟南山回乡传授长寿秘诀. www.taihainet.com (in Chinese (China)). Archived from the original on 25 January 2020. Retrieved 21 January 2020.
  10. 1 2 3 4 5 Ye 叶, Yi 依 (2010). 钟南山传. Beijing: 作家出版社. pp. 49–52. ISBN   978-7-5063-5267-3.
  11. 1 2 "Meet Dr. Zhong Nanshan, The Public Face Of The COVID-19 Fight In China". NPR.org.
  12. ↑ Liu, Jie. "Zhong Nanshan: outspoken doctor awarded China's top honor".
  13. ↑ "钟南山：有充足证据证明连花清瘟对新冠肺炎有效". www.cdctj.com.cn. Retrieved 28 May 2021.
  14. ↑ 观察者网 (8 May 2020). "中国推荐有效药，瑞典：成分只是薄荷醇，禁止进口". finance.sina.com.cn. Retrieved 28 May 2021.
  15. ↑ "钟南山否认商业代言传闻：我怎么会做那些东西 | 每经网". www.nbd.com.cn. Retrieved 28 May 2021.
  16. ↑ "Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper". Retraction Watch. 4 May 2021. Retrieved 4 May 2021.
  17. 1 2 "Tencent teams up with 'Sars hero' on AI, big data lab to tackle coronavirus". South China Morning Post. 28 February 2020. Retrieved 3 June 2024.
  18. ↑ "Government announces decorations and medals for 2020". Government of Macau . 19 December 2020. Retrieved 31 August 2021.
  19. ↑ 习近平签署主席令 授予钟南山等4人国家勋章、国家荣誉称号. Ifeng (in Chinese (China)). 11 August 2020.
  20. ↑ Wang, Shuo (王硕) (1 June 2016). 政解|中国工程院光华"成就奖"为何两度空缺？. Ifeng News (in Chinese (China)).
  21. 1 2 3 4 5 6 7 8 9 10 11 12 13 Curriculum Vitae of Nan-Shan ZHONG (PDF). 澳門科技大學. 2013 [2020-02-09].
  22. ↑ 为自己塑像揭幕惊诧众人 钟南山人设遭遇两极分化. 163.com (in Chinese). 16 December 2020. Retrieved 22 December 2020.
  23. ↑ Summerskill, W. (2009). Paper of the year 2008: results. The Lancet, 373(9660), 283–284.
  24. ↑ Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 2008; 371: 2013–18.
  25. ↑ Honorary Editors-in-Chief: Nanshan Zhong, MD. Annals of Translational Medicine. [2020-02-09].
  26. ↑ 鍾雪冰 (23 March 2007). 鍾南山膺愛丁堡大學榮譽博士. 香港文匯報 (in Chinese (Hong Kong)). Retrieved 9 February 2020.
  27. ↑ 梁元生 (2013). 第73屆大會 (2013) 鍾南山院士榮譽理學博士 (in Chinese (Hong Kong)). Chinese University of Hong Kong. Retrieved 9 February 2020.
  28. ↑ 钟南山的妻子是女篮５号. Sina (in Chinese (China)). 16 June 2003. Archived from the original on 16 September 2019. Retrieved 13 February 2019.
  29. ↑ 钟南山曾是400米栏全国纪录保持者 娶女篮名将为妻. Sina (in Chinese (China)). 22 January 2020. Archived from the original on 22 January 2020. Retrieved 22 January 2020.
Academic offices
Previous:
Zhang Wenkang 		President of Chinese Medical Association
2005–2010		Next:
Chen Zhu
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.